MOA Life Plus Co. Ltd.

KOSDAQ:A142760 Stock Report

Market Cap: ₩16.3b

MOA Life Plus Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MOA Life Plus.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth21.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article Jan 22

Is MOA Life Plus (KOSDAQ:142760) Using Debt In A Risky Way?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Oct 01

Is MOA Life Plus (KOSDAQ:142760) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jun 10

MOA Life Plus Co. Ltd.'s (KOSDAQ:142760) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

MOA Life Plus Co. Ltd. ( KOSDAQ:142760 ) shareholders have had their patience rewarded with a 26% share price jump in...
Analysis Article Feb 06

Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Oct 18

Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Apr 19

There's No Escaping Bioleaders Corporation's (KOSDAQ:142760) Muted Revenues Despite A 30% Share Price Rise

Bioleaders Corporation ( KOSDAQ:142760 ) shares have continued their recent momentum with a 30% gain in the last month...
Analysis Article Mar 01

Bioleaders Corporation's (KOSDAQ:142760) Business And Shares Still Trailing The Industry

You may think that with a price-to-sales (or "P/S") ratio of 0.5x Bioleaders Corporation ( KOSDAQ:142760 ) is...
Analysis Article Feb 16

Bioleaders' (KOSDAQ:142760) Shareholders Are Down 47% On Their Shares

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MOA Life Plus has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A142760 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202610,452-12,769-4,736-4,228N/A
12/31/202511,216-13,031-6,183-5,970N/A
9/30/20259,800-11,929-5,333-5,259N/A
6/30/202512,160-12,869-4,566-4,548N/A
3/31/202513,787-4,93413,85814,903N/A
12/31/202415,630-6,994-1,555-502N/A
9/30/202417,080-11,283-2,546-1,409N/A
6/30/202418,436-12,016-257610N/A
3/31/202418,548-8,922-18,695-18,349N/A
12/31/202318,245-6,2045,7966,175N/A
9/30/2023-40,63610,7423,7414,345N/A
6/30/2023-16,1109,543-8,859-7,262N/A
3/31/20231,909-205-15,079-13,494N/A
12/31/202222,004-2,468-22,403-20,602N/A
9/30/2022104,738-26,148-16,623-14,981N/A
6/30/202299,393-21,284-6,413-5,337N/A
3/31/2022100,298-19,159-7,944-5,839N/A
12/31/2021101,170-19,768-7,230-5,036N/A
9/30/202198,814-15,688-10,488-6,409N/A
6/30/202192,955-23,184-24,584-14,100N/A
3/31/202185,999-21,778-28,573-14,432N/A
12/31/202080,453-21,138-23,335-5,426N/A
9/30/202067,761-24,862-37,185-9,434N/A
6/30/202066,300-22,324-20,6497,014N/A
3/31/202067,138-27,900-17,9867,596N/A
12/31/201972,877-28,046N/A-2,195N/A
9/30/201987,455-24,525N/A3,213N/A
6/30/201998,845-23,286N/A-6,544N/A
3/31/2019107,313-17,111N/A-6,361N/A
12/31/201886,067-17,228N/A-8,770N/A
9/30/201862,205-9,137N/A-14,278N/A
6/30/201834,764-8,111N/A-13,774N/A
3/31/201811,497-7,829N/A-9,680N/A
12/31/20177,607-6,647N/A-8,525N/A
12/31/20162,501-5,896N/A-7,697N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A142760's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A142760's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A142760's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A142760's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A142760's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A142760's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 08:48
End of Day Share Price 2026/07/13 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MOA Life Plus Co. Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.